Joyce Man‐Fong Lee

5.1k total citations · 2 hit papers
42 papers, 3.9k citations indexed

About

Joyce Man‐Fong Lee is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Joyce Man‐Fong Lee has authored 42 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 23 papers in Cancer Research and 13 papers in Oncology. Recurrent topics in Joyce Man‐Fong Lee's work include RNA modifications and cancer (9 papers), Epigenetics and DNA Methylation (8 papers) and Cancer-related molecular mechanisms research (8 papers). Joyce Man‐Fong Lee is often cited by papers focused on RNA modifications and cancer (9 papers), Epigenetics and DNA Methylation (8 papers) and Cancer-related molecular mechanisms research (8 papers). Joyce Man‐Fong Lee collaborates with scholars based in Hong Kong, China and United States. Joyce Man‐Fong Lee's co-authors include Irene Oi‐Lin Ng, Chun‐Ming Wong, Carmen Chak‐Lui Wong, Felice Ho‐Ching Tsang, Daniel Wai‐Hung Ho, Lai Wei, Sandy Leung–Kuen Au, Cheuk‐Ting Law, David Kung‐Chun Chiu and Mengnuo Chen and has published in prestigious journals such as Nature Communications, Gastroenterology and PLoS ONE.

In The Last Decade

Joyce Man‐Fong Lee

40 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

RNA N6‐methyladenosine methyltransferase‐like 3 promotes liver cancer progression through YTHDF2‐dependent posttranscriptional silencing of SOCS2

2017 1.0k citations Mengnuo Chen, Lai Wei et al. Hepatology profile →
Single-cell RNA sequencing shows the immunosuppressive landscape and tumor heterogeneity of HBV-associated hepatocellular carcinoma

2021 214 citations Daniel Wai‐Hung Ho, Yu‐Man Tsui et al. Nature Communications profile →

Peers

Countries citing papers authored by Joyce Man‐Fong Lee

Since Specialization

Citations

This map shows the geographic impact of Joyce Man‐Fong Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joyce Man‐Fong Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joyce Man‐Fong Lee more than expected).

Fields of papers citing papers by Joyce Man‐Fong Lee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joyce Man‐Fong Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joyce Man‐Fong Lee. The network helps show where Joyce Man‐Fong Lee may publish in the future.

Co-authorship network of co-authors of Joyce Man‐Fong Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Joyce Man‐Fong Lee. A scholar is included among the top collaborators of Joyce Man‐Fong Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joyce Man‐Fong Lee. Joyce Man‐Fong Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	GPD1L supports glycerol-3-phosphate and triacylglycerol synthesis and promotes tumor progression in HCC 2025 ·Hepatology ·(unknown), Luqing Zhao, Karen Man‐Fong Sze, Lü Tian, Xin Zhang, Eva Lee, (unknown), Joyce Man‐Fong Lee, Daniel Wai‐Hung Ho, (unknown), Lo‐Kong Chan, Irene Oi‐Lin Ng	1
2	Targeting sterol O-acyltransferase 1 rewires fatty acid metabolism and uncovers immune vulnerability in hepatocellular carcinoma 2025 ·Hepatology ·Huanhuan Ma, Xin Zhang, (unknown), Joyce Man‐Fong Lee, Eva Lee, (unknown), Huan Deng, Fanhong Zeng, Daniel Wai‐Hung Ho, Christy Lai Ming Hui, (unknown), Karen Man‐Fong Sze, Irene Oi‐Lin Ng	0
3	Resolution of Optimal Mitochondrial and Nuclear DNA Enrichment in Target-Panel Sequencing and Physiological Mitochondrial DNA Copy Number Estimation in Liver Cancer and Non-Liver Cancer Subjects 2024 ·Cancers ·Xueying Lyu, Yu‐Man Tsui, (unknown), (unknown), (unknown), Joyce Man‐Fong Lee, Irene Oi‐Lin Ng, Daniel Wai‐Hung Ho	1
4	Transcription factor AP-4 reactivates telomerase reverse transcriptase independently of genome alteration in non-HBV associated hepatocellular carcinoma 2024 ·(unknown), (unknown), (unknown), (unknown), Joyce Man‐Fong Lee, Yu‐Man Tsui, Daniel Wai‐Hung Ho, Karen Man‐Fong Sze, Irene Oi‐Lin Ng	0
5	Reciprocal interactions between malignant cells and macrophages enhance cancer stemness and M2 polarization in HBV-associated hepatocellular carcinoma 2024 ·Theranostics ·Qingyang Zhang, Yu‐Man Tsui, Xin Zhang, (unknown), Joyce Man‐Fong Lee, (unknown), (unknown), (unknown), Elaine Tin-Yan Cheung, Nam-Hung Chia, Irene Lo, Albert Chan, Tan To Cheung, Irene Oi‐Lin Ng, Daniel Wai‐Hung Ho	23
6	Midline 1 interacting protein 1 promotes cancer metastasis through FOS-like 1-mediated matrix metalloproteinase 9 signaling in HCC 2023 ·Hepatology ·Yung‐Tuen Chiu, (unknown), Karen Man‐Fong Sze, Daniel Wai‐Hung Ho, (unknown), Xia Wang, Eva Lee, (unknown), Joyce Man‐Fong Lee, Lo‐Kong Chan, Irene Oi‐Lin Ng	9
7	Multimodal Integrative Genomics and Pathology Analyses in Neoadjuvant Nivolumab Treatment for Intermediate and Locally Advanced Hepatocellular Carcinoma 2023 ·Liver Cancer ·Tan To Cheung, Daniel Wai‐Hung Ho, (unknown), Qingyang Zhang, Yu‐Man Tsui, (unknown), Karen Man‐Fong Sze, Joyce Man‐Fong Lee, (unknown), (unknown), Simon H. Y. Tsang, Wong Hoi She, Roland Leung, Thomas Yau, Irene Oi‐Lin Ng	7
8	Single-cell RNA sequencing shows the immunosuppressive landscape and tumor heterogeneity of HBV-associated hepatocellular carcinoma breakdown → 2021 ·Nature Communications ·Daniel Wai‐Hung Ho, Yu‐Man Tsui, Lo‐Kong Chan, Karen Man‐Fong Sze, Xin Zhang, Jacinth Wing‐Sum Cheu, Yung‐Tuen Chiu, Joyce Man‐Fong Lee, Albert Chan, Elaine Tin-Yan Cheung, Derek Yau, Nam-Hung Chia, Irene Lo, Pak C. Sham, Tan-To Cheung, Carmen Chak‐Lui Wong, Irene Oi‐Lin Ng	214
9	Histone chaperone FACT complex mediates oxidative stress response to promote liver cancer progression 2019 ·Gut ·Jialing Shen, Mengnuo Chen, Derek Lee, Cheuk‐Ting Law, Lai Wei, Felice Ho‐Ching Tsang, Don Wai‐Ching Chin, (unknown), Joyce Man‐Fong Lee, Irene Oi‐Lin Ng, Carmen Chak‐Lui Wong, Chun‐Ming Wong, (unknown), (unknown)	42
10	HELLS Regulates Chromatin Remodeling and Epigenetic Silencing of Multiple Tumor Suppressor Genes in Human Hepatocellular Carcinoma 2018 ·Hepatology ·Cheuk‐Ting Law, Lai Wei, Felice Ho‐Ching Tsang, Cerise Yuen‐Ki Chan, Mingjing Xu, Robin Kit‐Ho Lai, Daniel Wai‐Hung Ho, Joyce Man‐Fong Lee, Carmen Chak‐Lui Wong, Irene Oi‐Lin Ng, Chun‐Ming Wong	59
11	AMPK Promotes p53 Acetylation via Phosphorylation and Inactivation of SIRT1 in Liver Cancer Cells 2012 ·Cancer Research ·Chi Wai Lee, Leo Lap-Yan Wong, (unknown), (unknown), Veronica Yee-Law Leong, Joyce Man‐Fong Lee, D. Grahame Hardie, Irene Oi‐Lin Ng, Ching C. Lau	180
12	Histone Lysine Methyltransferase, Suppressor of Variegation 3-9 Homolog 1, Promotes Hepatocellular Carcinoma Progression and Is Negatively Regulated by MicroRNA-125b 2012 ·Hepatology ·Dorothy Ngo-Yin Fan, Felice Ho‐Ching Tsang, (unknown), Sandy Leung–Kuen Au, Carmen Chak‐Lui Wong, (unknown), Lai Wei, Joyce Man‐Fong Lee, Xianghuo He, Irene Oi‐Lin Ng, Chun‐Ming Wong	95
13	The centrosomal protein tax1 binding protein 2 is a novel tumor suppressor in hepatocellular carcinoma regulated by cyclin-dependent kinase 2 2012 ·Hepatology ·(unknown), (unknown), Leo Lap-Yan Wong, Yuan Zhou, Veronica Yee-Law Leong, Joyce Man‐Fong Lee, Irene Oi‐Lin Ng, Dong‐Yan Jin, Ching C. Lau	13
14	Overexpression of a Novel Activator of PAK4, the CDK5 Kinase–Associated Protein CDK5RAP3, Promotes Hepatocellular Carcinoma Metastasis 2011 ·Cancer Research ·Grace Wing-Yan Mak, (unknown), Veronica Yee-Law Leong, Joyce Man‐Fong Lee, Tai-On Yau, Irene Oi‐Lin Ng, Ching C. Lau	69
15	Sequential alterations of microrna expression in hepatocellular carcinoma development and venous metastasis 2011 ·Hepatology ·Chun‐Ming Wong, Carmen Chak‐Lui Wong, Joyce Man‐Fong Lee, Dorothy Ngo-Yin Fan, Sandy Leung–Kuen Au, Irene Oi‐Lin Ng	90
16	Genome-Wide Association Study of Hepatocellular Carcinoma in Southern Chinese Patients with Chronic Hepatitis B Virus Infection 2011 ·PLoS ONE ·Kelvin Y.K. Chan, Chun‐Ming Wong, Johnny S. H. Kwan, Joyce Man‐Fong Lee, Ka Wai Cheung, Man‐Fung Yuen, Ching‐Lung Lai, Ronnie Tung‐Ping Poon, Pak C. Sham, Irene Oi‐Lin Ng	48
17	The MicroRNA miR-139 Suppresses Metastasis and Progression of Hepatocellular Carcinoma by Down-regulating Rho-Kinase 2 2010 ·Gastroenterology ·Carmen Chak‐Lui Wong, Chun‐Ming Wong, (unknown), Sandy Leung–Kuen Au, Joyce Man‐Fong Lee, Ronnie Tung‐Ping Poon, Kwan Man, Irene Oi‐Lin Ng	254
18	Hepatitis B Virus–Associated Multistep Hepatocarcinogenesis: A Stepwise Increase in Allelic Alterations 2008 ·Cancer Research ·Joyce Man‐Fong Lee, Chun‐Ming Wong, Irene Oi‐Lin Ng	29
19	Tissue factor pathway inhibitor‐2 as a frequently silenced tumor suppressor gene in hepatocellular carcinoma† 2007 ·Hepatology ·Chun‐Ming Wong, (unknown), Joyce Man‐Fong Lee, Carmen Chak‐Lui Wong, O. T. Cheung, Chung–Yiu Chan, Edmund Kwok–Kwan Tung, Ching C. Lau, Irene Oi‐Lin Ng	89
20	High‐density allelotyping of chromosome 8p in hepatocellular carcinoma and clinicopathologic correlation 2002 ·Cancer ·Kok‐Lung Chan, Joyce Man‐Fong Lee, Xin‐Yuan Guan, (unknown), Irene Oi‐Lin Ng	42

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact